Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This study will investigate the safety, tolerability, pharmacokinetic, and pharmacodynamic response of patients with cystic fibrosis to administration of QAU145 via intranasal spray.
Epistemonikos ID: e5a02985bae43b7b5ec019739f335ed69031d993
First added on: May 04, 2024